The best fit

ArrayGenomics partners with medica institutions

The BCA test from ArrayGenomics is the molecular test of choice for clinicians working in bladder cancer. 

  1. Patient care:  Higher sensitivity than all known tests including cystoscopy.

  2. Patient welfare: The BCA test is non-invasive. 

  3. Ease of implementation: The BCA test uses CGH technology and a laser scanner to analyse bladder cancers. 

  4. Health economics:  The BCA test can be used in place of unnecessary cystoscopies, This could represent significant savings for health authorities

    Contact ArrayGenomics now to find out how you can obtain the BCA test. The BCA test is for research use only: not for use in diagnostic procedures.